The French biotechnology firm aims to develop therapies for various neurological conditions using its non-replicating HSV-1 vector technology.

Tencent Cloud and Vector Group's Offshore Company Launch Japan's First AI Avatar Video Generation Service "AvaMo” ...

Tozaro, an emerging technology provider in the field of cell and gene therapy manufacturing, announces the formation of its ...

Data highlights advantages of single, non-replicative HSV-1 (nrHSV-1) vector hosting two transgenes with independent ...

NewBiologix, a next-generation biotechnology company pioneering the future of recombinant adeno-associated virus (rAAV) production through a unique DNA-based platform built on stable cell line ...

The Gates Foundation committed $5.4 billion in 2024, roughly a third of which went to global health programs. Who were the ...

Home > Pressemitteilung: Medicine meets technology: promoting ... Kurt Alten Foundation supports clinical scientist at MHH in transferring innovative medical-technological approaches to improve liver ...

The Battery Workforce Challenge names champions for year two, highlighting student achievements in EV battery design and ...

Xmoor Pharma has entered into a strategic partnership with KU Leuven to support a new cell and gene therapy hub.

LONDON and NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced financial and operational ...

Learn about the Defense Information Systems Agency's top priorities and needs as explained by Deputy Director Christopher ...

A year after being taken over by Mitsubishi UFJ Trust and Banking Corporation, the New Zealand share registry and financial ...